Detecting Ovarian Cancer Biomarker with a New Sensor
Author Information
Author(s): Davoudian Katharina, Spagnolo Sandro, Chan Edmund, Hianik Tibor, Thompson Michael
Primary Institution: Department of Chemistry, University of Toronto
Hypothesis
Can a new acoustic sensor effectively detect lysophosphatidic acid (LPA), a biomarker for early-stage ovarian cancer, in human serum?
Conclusion
The developed sensor successfully detected LPA in undiluted human serum, demonstrating its potential for early-stage ovarian cancer diagnosis.
Supporting Evidence
- LPA levels are elevated across all stages of ovarian cancer and increase with disease progression.
- The sensor achieved a low limit of detection of 1.0 μM in phosphate-buffered saline and 0.7 μM in human serum.
- The antifouling properties of the new thiol linker improved the sensor's performance in complex biological samples.
Takeaway
Researchers created a special sensor that can find a substance in the blood that helps detect ovarian cancer early, which is really important for treatment.
Methodology
The study used a thickness shear mode acoustic sensor with dissipation monitoring to detect LPA in human serum.
Limitations
The study did not collect genetic or metabolic information from the blood sample, and the effects of serum components on detection sensitivity need further investigation.
Participant Demographics
The study involved a healthy male donor who provided blood for measurements.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website